Dimetapp hasn’t been taken off the market. It’s just that the FDA warned that inexact dosing could lead to an overdose in children; GSK has not reported any adverse effects so far.
The recalled lots of Robitussin and Dimetapp were distributed nationwide between Feb. 5 and June 3 and carry the GSK and Pfizer brand names on their labels.
Get more content like this and the inside gist on all the fun things that happen at Healthsoothe straight to your inbox when you Subscribe to the Healthsoothe newsletter. Do it now!
